Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-11

FDA Approved: TREPROSTINIL — Original Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Alembic Pharmaceuticals' original ANDA for treprostinil, enabling the generic version of the drug to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Treprostinil (treprostinil)

Snippet

ORIG AP for TREPROSTINIL (TREPROSTINIL)